Trials Sponsors Conditions Drugs Pricing

Conditions

Oncology Taste, Altered

Keywords

Oral nutritional supplementOncologyTaste alterations

Outcome Measures

Primary Outcomes (1)

Choice for the Fortimel/Nutridrink Compact Protein sensation flavour over the Fortimel/Nutridrink Compact Protein regular flavour
Subjects take one sensation flavour and one regular flavour and are asked in a direct question which flavour they prefer.
On 4 days

Secondary Outcomes (3)

Difference between average liking scores [score 0-10] for Fortimel/Nutridrink Compact Protein sensation flavour range versus Fortimel/Nutridrink Compact Protein regular flavour range
On 4 days
Choice for the Fortimel/Nutridrink Compact Protein sensation flavours over the Fortimel/Nutridrink Compact Protein regular flavours between patients with and patients without Taste and Smell Alterations
On 4 days
Difference in average liking scores [score 0-10] for Fortimel/Nutridrink Compact Protein sensation flavour versus Fortimel/Nutridrink Compact Protein regular flavour between patients with and patients without Taste and Smell Alterations
On 4 days

Study Arms (1)

Fortimel/Nutridrink Compact Protein

EXPERIMENTAL

Twice daily serving of the study product

Dietary Supplement: Fortimel/Nutridrink Compact Protein

Interventions

Fortimel/Nutridrink Compact ProteinDietary supplement

Twice daily serving of the study product

Fortimel/Nutridrink Compact Protein

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Being diagnosed with cancer
Undergoing, or having undergone systemic anti-cancer treatment or radiotherapy in the past 12 months.

Sponsors & Collaborators

Nutricia Research
Industrylead

Study Sites (1)

Nutricia Clinical Research Unit

Utrecht, Netherlands

MeSH Terms

Conditions

NeoplasmsDysgeusia

Condition Hierarchy (Ancestors)

Taste DisordersSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Enrollment

64 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NA
Masking: NONE
Purpose: SUPPORTIVE CARE
Intervention Model: SINGLE GROUP
Sponsor Type: INDUSTRY
Responsible Party: SPONSOR

Study Record Dates

First Submitted

August 10, 2022

First Posted

August 29, 2022

Study Start

October 6, 2022

Actual (reported)

Assessment of ONS-flavour Preference in Cancer Patients With and Without Taste Alterations

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (3)

Study Arms (1)

Fortimel/Nutridrink Compact Protein

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (3)

Study Arms (1)

Fortimel/Nutridrink Compact Protein

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations